menu
    • menu

    Company profile for ALK

    NEW Drugs in Dev: 33
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ALK is a global allergy solutions company, with a wide range of allergy treatments, products and services that meet the unique needs of allergy sufferers, their families and healthcare professionals. At ALK, we have a proud heritage of pioneer research dating all the way back to our founders nearly 100 years ago. Back then, research was small-scale, the evidence for allergy immunotherapy was limited and medical science was sti...
    ALK is a global allergy solutions company, with a wide range of allergy treatments, products and services that meet the unique needs of allergy sufferers, their families and healthcare professionals. At ALK, we have a proud heritage of pioneer research dating all the way back to our founders nearly 100 years ago. Back then, research was small-scale, the evidence for allergy immunotherapy was limited and medical science was still in its infancy. Over the decades, things have changed immensely, and ALK has been responsible for many of the innovations we now take for granted in our understanding of allergy and its treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ALKDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Bøge Allé 6-8 DK-2970 Hørsholm
    Telephone
    Telephone
    (+45) 4574 7576
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alk.net/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alk-abello
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/alk_net?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annual General Meeting In ALK-Abelló A/S Held On 16 March 2026
    Annual General Meeting In ALK-Abelló A/S Held On 16 March 2026

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256594/0/en/Annual-General-Meeting-in-ALK-Abell%C3%B3-A-S-held-on-16-March-2026.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    ALK To Present 2025 Annual Report On February 20, 2026
    ALK To Present 2025 Annual Report On February 20, 2026

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3237968/0/en/Invitation-to-the-presentation-of-ALK-s-annual-report-2025-on-Friday-20-February-2026.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    ALK Gets Recommendation for EURneffy 1 mg for Anaphylaxis
    ALK Gets Recommendation for EURneffy 1 mg for Anaphylaxis

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3228809/0/en/ALK-receives-positive-recommendation-for-EURneffy-1-mg-A-needle-free-anaphylaxis-treatment-for-children.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    ALK to Present at 44th Annual J.P. Morgan Healthcare Conference
    ALK to Present at 44th Annual J.P. Morgan Healthcare Conference

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215621/0/en/ALK-to-present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference-in-San-Francisco.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Major Shareholder Announcement
    Major Shareholder Announcement

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208755/0/en/Major-shareholder-announcement.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Alk Appoints Edward as New EVP & Head of Commercial Operations
    Alk Appoints Edward as New EVP & Head of Commercial Operations

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197134/0/en/ALK-appoints-Edward-Jordan-as-new-EVP-and-head-of-Commercial-Operations-North-America.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search